Next Article in Journal
Trehalose Metabolism: From Osmoprotection to Signaling
Previous Article in Journal
The Improvement of Hypertension by Probiotics: Effects on Cholesterol, Diabetes, Renin, and Phytoestrogens
Int. J. Mol. Sci. 2009, 10(9), 3776-3792; doi:10.3390/ijms10093776

The Reversal of Drug-Resistance in Tumors Using a Drug-Carrying Nanoparticular System

1 College of Pharmacy, Chung-Ang University, 221 Heukseok dong, Seoul 155-756, Korea 2 Division of Biotechnology, The Catholic University of Korea, 43-1 Yeokgok 2-dong, Wonmi-gu, Bucheon-si, Gyeonggi-do 420-743, Korea 3 Department of Diagnostic Radiology, Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, Seoul, 120-752, Korea 4 College of Pharmacy, Pusan National University, Jangjun-dong, Geumjeong-gu, Busan 609-735, Korea # These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 4 August 2009 / Accepted: 26 August 2009 / Published: 31 August 2009
(This article belongs to the Section Biochemistry, Molecular Biology and Biophysics)
View Full-Text   |   Download PDF [487 KB, uploaded 19 June 2014]   |  


Medical applications of nanoparticular systems have attracted considerable attention because of their potential use in therapeutic targeting of disease tissues and their lower level of toxicity against healthy tissue, relative to traditional pharmaceutical drugs. The use of nanoparticular systems has been shown to overcome the limitations of most anticancer drugs in clinical applications. In particular, the improved performance of smarted nanoparticular system for solving the drug resistance problems that typically interrupt tumor treatment has provided a promising strategy for successful tumor chemotherapy. This review highlights recent studies that have examined the therapeutic effect of nanoparticular systems on drug-resistant tumors and presents insight on how they work.
Keywords: multi-drug resistance; nanoparticle; tumor treatment; drug delivery system multi-drug resistance; nanoparticle; tumor treatment; drug delivery system
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Oh, K.T.; Baik, H.J.; Lee, A.H.; Oh, Y.T.; Youn, Y.S.; Lee, E.S. The Reversal of Drug-Resistance in Tumors Using a Drug-Carrying Nanoparticular System. Int. J. Mol. Sci. 2009, 10, 3776-3792.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert